NEW YORK (GenomeWeb News) – Cellectis Group today announced that its stem cell business unit Ectycell has merged with Cellectis bioresearch.

Cellectis Group also announced a €3.5 million ($4.1 million) capital increase into Cellectis bioresearch, which was subscribed for by French financial organization Caisse des Depots.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.